Medication info
Rosunex Tablet 10mg (Rosuvastatin Calcium)

Rosunex Tablet 10mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium Micronized›10.4mg / 1 tablet
Manufacturer / importer
Bionex Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201400352 · Approved 2014.01.27 · Insurance code 643103730

Summary

Main use
Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and reduction of cardiovascular disease risk
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. 3. Older adults: Dose adjustment is not necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Child dose
Aged 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and reduction of cardiovascular disease risk

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary heart disease
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
View approved original text

This medication is primarily used as an adjunctive therapy in cases of primary hypercholesterolemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia where dietary management and exercise are insufficient. It also helps reduce total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby slowing the progression of atherosclerosis. It is effective for children aged 10 to 17 with heterozygous familial hypercholesterolemia, reducing LDL cholesterol and Apo-B levels to lower the risk of cardiovascular diseases. Additionally, it can be used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia. Moreover, it contributes to reducing the risk of stroke, myocardial infarction, and arterial revascularization in men over 50 and women over 60 with specific cardiovascular risk factors. Thus, it is effectively used for the reduction of various dyslipidemias and cardiovascular disease risks.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. 3. Older adults: Dose adjustment is not necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Child dose

Aged 10 years to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to any ingredient of this medication, those with severely impaired liver function, patients with muscle disorders, patients taking certain immunosuppressants, those with significantly decreased kidney function, pregnant or breastfeeding women, and patients with genetic metabolic disorders like lactose intolerance should avoid this medication. Additionally, caution should be exercised when administering this medication to patients who consume large amounts of alcohol or have a history of liver disease, and it is essential to repeat liver function tests before and during treatment. Patients with hypercholesterolemia caused by hypothyroidism or nephrotic syndrome should first treat the underlying condition. If symptoms like muscle pain, muscle weakness, or cramps occur while taking this medication, the healthcare provider should be informed immediately, and muscle enzyme tests may be necessary to check for muscle damage. Especially patients with decreased kidney function, the elderly, alcohol abusers, and those with a family history of muscle disorders should be monitored more closely for the risk of muscle abnormalities. This medication may affect liver function, potentially raising liver enzyme levels, so it should be discontinued immediately if signs of liver dysfunction occur. Rarely, severe skin reactions or severe muscle weakness, interstitial lung disease, etc., can occur, and if such symptoms arise, treatment should be stopped immediately, and a healthcare provider should be consulted. This medication may interact with other drugs; therefore, caution is needed, particularly when taken in conjunction with certain antivirals, immunosuppressants, fibrates, some antibiotics, and antifungals. When co-administered with some medications, the blood concentration of this drug may increase, raising the risk of muscle damage. Therefore, dosage adjustments and close monitoring are necessary when used in combination. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraceptive methods. If pregnancy is confirmed during treatment, the medication should be discontinued immediately. In case of overdose, there are no specific antidotes, so treatment is symptomatic, and liver function and muscle enzyme levels should be monitored continuously. Finally, while this medication is not known to significantly affect driving or operating machinery, caution is advised as symptoms like dizziness may occur.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, forgetfulness, amnesia, memory disorder, confusion, increase in ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, discomfort in the chest, loss of appetite, abdominal distention, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture exposure. It is best to keep it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.